Main Menu

Merit Medical Systems, Inc.


Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Merit Medical Systems, Inc. ("Merit") on behalf of stockholders.  A class action complaint has been filed against Merit, which alleges that defendants made false and misleading statements and/or failed to disclose adverse information regarding Merit’s business and prospects. Specifically, defendants allegedly failed to disclose that: (i) the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, caused operational disruptions and reduced sales and were months behind schedule; (ii) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, particularly for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; and (iii) accordingly, Merit's reported financial guidance for fiscal years 2019 and 2020 was made without a reasonable basis.  Therefore, Merit stock traded at artificially inflated prices of more than $62 per share.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 07/17/2024

* Indicates a required field.

Back to Page